Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2021 August;112(4) > Minerva Medica 2021 August;112(4):528-9

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

LETTERS TO THE EDITOR   

Minerva Medica 2021 August;112(4):528-9

DOI: 10.23736/S0026-4806.19.06248-7

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

MiR-616 promotes the progression of pancreatic carcinoma by targeting OXR1

Yi ZHOU 1, Ping MENG 2, Biao TANG 1, Zhangming KE 1, Liming LIU 1, Yifa CHEN 1, Fan ZHU 1

1 Department of General Surgery, Ezhou Central Hospital, Ezhou, China; 2 Department of Oncology, Ezhou Central Hospital, Ezhou, China



top of page